У нас вы можете посмотреть бесплатно From P-Value to PI-ValueThe New Biogen, Straight From Its Chief Medical Officer или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Daniel Quirk joins William Soliman to offer a clear look at how the new @biogen has embraced its CEO’s vision and turned it into action that actually reaches patients. At the center is focus. Biogen has made deliberate choices to focus on Neuroscience, Rare Disease, and Immunology, where it has the depth, experience, and scientific credibility to truly make a difference. Hear how that focus is showing up in an incredible pipeline built for delivery, with a robust 10 assets advancing and a steady cadence of clinical readouts designed to translate innovation into real-world care. Under Daniel’s leadership, his 20 years of bedside care as a physician come through in how Medical Affairs is viewed as an extension of patient care. The goal is not just to explain data, but to turn complex science into practice-informing insights that help clinicians make better decisions for the patients in front of them. AI plays a role here, but only when it is used to solve a real problem, is measurable, and clearly improves outcomes. It’s a grounded, human view of leadership in biopharma: clear priorities, accountable innovation, and an unwavering focus on getting meaningful therapies to the people who need them most. #Biogen #ACMA #MedicalAffairs #BiopharmaLeadership #PatientFirst #Neuroscience #RareDisease #Immunology #ClinicalInnovation #PracticeInformingValue #AIInHealthcare #willsolimanpodcast Connect With Me: / drwilliamsoliman / will_soliman / williamsoliman1 / willsoliman Dr. William Soliman is the Founder and CEO of the Accreditation Council for Medical Affairs (ACMA) and a recognized pharmaceutical industry futurist. With over 20 years of experience holding key leadership roles at companies like Merck, AbbVie, and Gilead Sciences, Will is dedicated to raising the standards of the industry. He is the architect behind the Board Certified Medical Affairs Specialist (BCMAS) program, the industry standard for medical affairs professionals. Will holds a Ph.D. from Columbia University and frequently contributes to major media outlets including Fox News, Forbes, and ABC News.